Cart
sales@molnova.com
Nicotinamide-N-oxide
CAS No. 1986-81-8
Nicotinamide-N-oxide( —— )
Catalog No. M13105 CAS No. 1986-81-8
Nicotinamide N - oxide is niacin related compounds, used in the study of nicotinic acid related granulocyte differentiation mechanism.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 50MG | 31 | In Stock |
|
| 100MG | 45 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNicotinamide-N-oxide
-
NoteResearch use only, not for human use.
-
Brief DescriptionNicotinamide N - oxide is niacin related compounds, used in the study of nicotinic acid related granulocyte differentiation mechanism.
-
DescriptionNicotinamide N - oxide is niacin related compounds, used in the study of nicotinic acid related granulocyte differentiation mechanism.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
Targetc-Myc
-
Recptorc-Myc
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1986-81-8
-
Formula Weight138.12
-
Molecular FormulaC6H6N2O2
-
Purity>98% (HPLC)
-
SolubilityLimited solubility
-
SMILESNC(=O)C1=C[N+]([O-])=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tian YJ, et al. Br J Nutr. 2014 May;111(9):1594-60
molnova catalog
related products
-
IRES-J007
An improved IRES inhibitor that blocks IRES-hnRNP A1 binding.
-
10074-A4
10074-A4 is a c-Myc binding compound that associates with c-Myc370–409 and behaves like a “ligand cloud” around a “protein cloud”, with distinct features from that of a non-binding ligand.
-
MYCi361
MYCi361 is an inhibitor of MYC (binding to MYC with Kd of 3.2 μM). MYCi361 is a small-molecule MYC inhibitors that inhibits the viability of MYC-dependent cancer cells including prostate cancer (MycCaP, LNCaP, and PC3), leukemia (MV4-11), lymphoma (HL-60 and P493-6), and neuroblastoma (SK-N-B2) with low-micromolar IC50 values.
